CD274 and breast carcinoma: Monypenny et al. found that ALIX depletion in breast cancer cells reduces exosomal PD-L1 release and increases cell surface PD-L1 expression while upregulating oncogenic signaling through epidermal growth factor receptor (EGFR) activity [25].